Akèy › Anplwayè › Nuvation Bio Inc
Nuvation Bio Inc: Salè H-1B ak pajon
Nuvation Bio Inc depoze 17 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 16. Medyèn salè yo ofri a: $235,000.
Èske Nuvation Bio Inc pajone visa H-1B?
Nuvation Bio Inc depoze 17 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 1, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| VP, Head of Clinical Operations | 4 | $354,000 |
| Director, Business Intelligence and Data Management | 2 | $220,000 |
| Director-Field Systems and Digital Enablement | 2 | $235,000 |
| Associate Director of Business Development | 2 | $163,297 |
| Vice President, Clinical Operations | 2 | $370,000 |
| Director of Corporate Development | 2 | $250,000 |
| Senior Scientist | 2 | $170,990 |
| Scientist I | 1 | $151,318 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 3 | $350,000 |
| FY2024 | 2 | $220,000 |
| FY2025 | 3 | $358,000 |
| FY2026 | 9 | $202,995 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Medical and Health Services Managers4
- Computer and Information Systems Managers4
- Medical Scientists, Except Epidemiologists3
- Market Research Analysts and Marketing Specialists2
- Natural Sciences Managers2
- Financial and Investment Analysts2
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Scientist | $170,990 Nivo IV | New York, NY | Jun 1, 2026 | Sep 4, 2026 | Certifye |
| Associate Director of Business Development | $168,819 Nivo IV | Jersey City, NJ | May 27, 2026 | Oct 1, 2026 | Certifye |
| Senior Scientist | $170,990 Nivo IV | New York, NY | May 27, 2026 | Oct 1, 2026 | Certifye |
| Director of Corporate Development | $250,000 Nivo IV | New York, NY | May 13, 2026 | May 20, 2026 | Certifye |
| Director of Corporate Development | $250,000 Nivo IV | New York, NY | May 12, 2026 | May 20, 2026 | Certifye |
| Vice President, Clinical Operations | $370,000 Nivo IV | San Francisco, CA | Apr 8, 2026 | Oct 1, 2026 | Certifye |
| Vice President, Clinical Operations | $370,000 Nivo IV | San Francisco, CA | Apr 8, 2026 | Oct 1, 2026 | Retire |
| Director-Field Systems and Digital Enablement | $235,000 Nivo IV | The Colony, TX | Jan 27, 2026 | Feb 5, 2026 | Certifye |
| Associate Director of Business Development | $157,775 Nivo IV | Jersey City, NJ | Jan 8, 2026 | Jan 15, 2026 | Certifye |
| VP, Head of Clinical Operations | $358,000 E-3 · Nivo IV | San Francisco, CA | Feb 25, 2025 | Apr 6, 2025 | Certifye |
| VP, Head of Clinical Operations | $358,000 E-3 · Nivo IV | San Francisco, CA | Dec 12, 2024 | Apr 6, 2025 | Certifye |
| Director-Field Systems and Digital Enablement | $235,000 Nivo III | New York, NY | Oct 14, 2024 | Nov 12, 2024 | Certifye |
| Director, Business Intelligence and Data Management | $220,000 Nivo II | San Jose, CA | Sep 17, 2024 | Sep 25, 2024 | Certifye |
| Director, Business Intelligence and Data Management | $220,000 Nivo II | San Jose, CA | Sep 12, 2024 | Sep 20, 2024 | Certifye |
| Scientist I | $151,318 Nivo IV | New York, NY | Jun 14, 2023 | Oct 1, 2023 | Certifye |
| VP, Head of Clinical Operations | $350,000 E-3 · Nivo IV | San Francisco, CA | Mar 1, 2023 | Apr 7, 2023 | Certifye |
| VP, Head of Clinical Operations | $350,000 E-3 · Nivo IV | New York, NY | Feb 28, 2023 | Apr 7, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).